TECTONIC THERAPEUTIC, INC. Convertible Preferred Stock, Shares Issued upon Conversion
TECTONIC THERAPEUTIC, INC. (TECX) had Convertible Preferred Stock, Shares Issued upon Conversion of 15.32 million shares as of 2018-06-25, per its 10-Q filed 2019-11-07.
Discontinued › Notes
us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion · last filed 2019-11-07
- 2018-06-25: Convertible Preferred Stock, Shares Issued upon Conversion 15.32M shares.
- 2018-03-31: Convertible Preferred Stock, Shares Issued upon Conversion 15.32M shares.
- 2017-12-31: Convertible Preferred Stock, Shares Issued upon Conversion 8.42M shares.
| Period end | Convertible Preferred Stock, Shares Issued upon Conversion |
|---|---|
| 2018-06-25 | 15.32M shares 10-Q · filed 2019-11-07 |
| 2018-03-31 | 15.32M shares 10-Q · filed 2019-05-13 |
| 2017-12-31 | 8.42M shares 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |